Portfolio company
Infinity Bio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company provides antibody reactome profiling services using its molecular indexing platform for biopharmaceutical, academic and government researchers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Infinimmune
This biotechnology company develops human-derived antibody therapeutics for pharmaceutical partners and patients with atopic dermatitis and other inflammatory diseases.
Teiko Bio
Teiko Bio develops immune profiling platforms using mass cytometry to provide drug target discovery and biomarker analysis for biopharmaceutical companies and clinical researchers.
Enpicom
This company develops bioinformatics software for immune repertoire sequencing data analysis to assist biotechnology and pharmaceutical firms in antibody discovery and development.
ImmuneSpec
This company provides immunopeptidomics analysis services to biotechnology and pharmaceutical firms to support vaccine development, immunotherapy research and biotherapeutic immunogenicity risk assessment.
Enzo Biochem
This company produces research reagents, including antibodies, assays and proteins, for academic research, biotechnology, pharmaceutical and diagnostic customers.
RoukenBio
This company provides immunology and bioassay research services for biopharmaceutical firms to support drug discovery and preclinical development.
Cognano
This company develops an artificial intelligence platform for antibody drug discovery and biomarker identification to support pharmaceutical firms and healthcare researchers.
Radiant Biotherapeutics
This company develops multi-specific antibody therapies to treat patients with cancer and infectious diseases.
